Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Vietnam Drug Maker Develops New Cholera Vaccine

This article was originally published in PharmAsia News

Executive Summary

Vietnam's Vaccine and Bio-Technology Products No. 1 says it has developed a cholera vaccine that is half again as effective as current drugs. The drug, being registered as mORACVAX, is expected to gain approval in time to treat a new outbreak of the disease. The director of Vietnam's National Institute of Hygiene and Epidemiology said the vaccine is 90 percent to 100 percent effective, compared with the 60 percent to 70 percent effectiveness of the current vaccine. The vaccine is expected to cost about $1.25 per dose, triple the cost of the current drug being administered. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts